PCOS is a common hormonal and metabolic condition that is characterized by irregular menstrual cycles and weight gain.
Polycystic ovary syndrome (PCOS) is a common hormonal and metabolic condition that can affect menstrual cycles, ovulation, hair, skin, weight, and fertility. Symptoms vary widely, and having one or two of these signs does not necessarily mean one has PCOS.
10 Common Signs of PCOS
- Heavy or prolonged periods - Changes in ovulation can sometimes lead to irregular or heavier bleeding.
- Irregular periods - Periods may occur infrequently, become unpredictable, or stop altogether.
- Persistent acne - Hormonal changes may lead to acne, particularly on the face, chest, and upper back.
- Excess facial or body hair - Increased hair growth on the face, chin, chest, abdomen, or other areas can occur due to elevated androgen levels.
- Weight gain or difficulty losing weight - PCOS can be linked with metabolic changes and insulin resistance.
- Thinning scalp hair - Some people experience hair thinning or hair loss, which includes male-pattern hair loss.
- Darkened skin patches - Dark, thicker areas of skin, mainly around the neck, armpits, or groin, may occur.
- Difficulty getting pregnant - Irregular or absent ovulation can make conception more difficult.
- Skin tags - The small and soft growths can develop around the neck or armpits.
- Oily skin and related hormonal changes - Increased oil production can accompany acne and a few androgen-related symptoms.
When should you see a doctor?
If you have persistent irregular periods, significant acne, excess hair growth, unexplained hair loss, or difficulty becoming pregnant, it is worth discussing these symptoms with a healthcare professional. Moreover, these symptoms can have several causes, so PCOS should not be diagnosed based on symptoms alone. Thus, diagnosis may involve medical history, hormone testing, examination, and sometimes an ultrasound.
How Common Is PCOS Among Reproductive-Age Women?
This table shows the estimated prevalence of PCOS globally and across commonly used diagnostic approaches.
| Population / Measure | Prevalence |
| Global reproductive-age women - WHO estimate | 10-13% |
| Global prevalence - broader research range | 6-20% |
| Women affected under broader diagnostic criteria. | Up to 13% |
| Women with PCOS who may remain undiagnosed | Up to 70% |
| Approximate number of women affected in every 100 reproductive-age women | Oct-13 |
| Approximate number of women affected in every 1,000 reproductive-age women | 100-130 |
Source: WHO; peer-reviewed PCOS literature.
PCOS is a chronic metabolic condition linked with heightened long-term risk for insulin resistance, type 2 diabetes mellitus, and obesity. There is currently no cure for PCOS, but lifestyle changes, medications, and fertility treatments can reduce symptoms, increase fertility rates, and protect longer-term health.
- The global prevalence among reproductive-age women, as per WHO estimates, is 10- 13%.
- The worldwide prevalence, based on broader research, ranges from 6- 20%.
- Women affected under broader diagnostic criteria are up to 13%. Women with PCOS who may remain undiagnosed are up to 70%.
- The approximate number of women affected in every 100 reproductive-age women is 10-1.
- The approximate number of women affected in every 1,000 reproductive-age women is 100-130.
What Are the Most Common PCOS Symptoms?
These are the principal clinical features recognized by major health authorities; exact symptom percentages vary substantially between studies and populations.
| PCOS Feature | Clinical Association |
| Irregular menstrual cycles | Common |
| Absent or infrequent periods | Common |
| Excess facial/body hair | Common |
| Acne and oily skin | Common |
| Scalp hair thinning | Common |
| Weight gain | Common |
| Difficulty losing weight | Common |
| Infertility/difficulty conceiving. | Common association |
| Darkened skin patches | Associated feature |
| Skin tags | Associated feature |
The most common symptom of polycystic ovary syndrome (PCOS), also referred to clinically as polyendocrine metabolic ovarian syndrome (PMOS) irregular menstrual cycles, absent or infrequent periods, excess facial or body hair, acne and oily skin, scalp hair thinning, weight gain, difficulty losing weight, infertility, or difficulty conceiving are all common associations. Thus, darkened skin patches and skin tags are associated features.
How Many Women with PCOS Remain Undiagnosed?
Delayed diagnosis is a major issue because PCOS can present through different reproductive, hormonal, metabolic, and dermatological symptoms.
| Measure | Statistic |
| Women with PCOS potentially undiagnosed globally | Up to 70% |
| Women with PCOS potentially diagnosed globally. | Up to 30% |
| Undiagnosed women per 100 affected women | Up to 70 |
| Diagnosed women per 100 affected women | Approximately 30 |
| Potentially undiagnosed women per 1,000 affected women | Up to 700 |
| Potentially diagnosed women per 1,000 affected women | Approximately 300 |
Source: WHO. These figures represent estimates and should not be interpreted as a universal diagnostic rate for every country.
PCOS is the leading cause of infertility in reproductive-aged women. It is associated with an increased risk of developing metabolic syndrome and its associated comorbidities, which include cardiovascular disease, diabetes, and obesity, throughout their life course. PCOS remains undiagnosed because the condition's classic name and overlapping symptoms hide its true metabolic roots.
- Women with PCOS are potentially undiagnosed globally; nearly 70% are undiagnosed, and up to 30% are diagnosed.
- Undiagnosed women per 100 affected women are approximately 70, and diagnosed women per 100 affected women are approximately 30.
- Potentially undiagnosed women per 1,000 affected women are nearly 700, and diagnosed women per 1,000 affected women are approximately 300.
What Is the Prevalence of PCOS in the United States?
U.S. estimates vary depending on whether the measure captures diagnosed PCOS or broader epidemiological prevalence.
| U.S. Measure | Figure |
| Women aged 20-49 ever diagnosed with PCOS, 2022-23 | 8.70% |
| Equivalent diagnosed cases per 100 women aged 20-49 | 8.7 |
| Equivalent diagnosed cases per 1,000 women aged 20-49 | 87 |
| Older estimated U.S. women affected | 5-7 million |
| Age at which PCOS can occur | As young as 11 years |
| U.S. women aged 20-49 without a reported diagnosis | 91.30% |
Source: CDC/NCHS and CDC PCOS resources.
The rise of PCOS, increasingly discussed as a polyendocrine metabolic condition in the United States, is driven by a combination of worsening metabolic health trends, better clinical awareness, and environmental exposures. Diets high in refined carbohydrates and added sugars, along with fast foods, cause sharp blood sugar spikes. Over time, these dietary habits fuel chronic low-grade inflammation and even metabolic dysfunction. Exposure to chemicals in plastics, like BPA and phthalates, pesticides, and other pollutants can interfere with normal hormonal signaling and endocrine function.
- Women aged 20-49 ever diagnosed with PCOS in 2022-23 are 8.7%.
- Equivalent diagnosed cases per 100 women aged 20-49 are 8.7.
- Equivalent diagnosed cases per 1,000 women aged 20-49 are 87.
- Older estimates state U.S. women affected are nearly 5-7 million.
- The age at which PCOS can occur in young people is 11 years.
- U.S. women aged 20-49 without a reported diagnosis are 91.3%.
What Is the PCOS Risk of Type 2 Diabetes?
PCOS is strongly associated with metabolic abnormalities, making glucose screening and long-term metabolic monitoring important areas of care.
| Diabetes-Related PCOS Statistic | Figure |
| Women with PCOS developing type 2 diabetes by age 40 - CDC statement | More than 50% |
| Women with PCOS without diabetes by age 40 - implied | Less than 50% |
| PCOS-related diabetes risk | Elevated |
| PCOS and insulin resistance | Strong clinical association |
| PCOS and hyperinsulinemia | Common metabolic association |
| PCOS and cardiometabolic risk | Elevated |
Source: CDC and peer-reviewed research.
Important: “More than 50%” is a CDC statement and should not be presented as a precise prevalence estimate for every PCOS population.
Women with PCOS usually have insulin resistance. This is when their bodies make insulin, a major hormone in balancing blood sugar, but they can't use it effectively. Thus, insulin resistance increases the risk of type 2 diabetes.
- Women with PCOS developing type 2 diabetes by age 40, according to a CDC statement, is more than 50%.
- Women with PCOS without diabetes by age 40 implies less than 50%.
- PCOS-related diabetes risk and cardiometabolic risk are elevated.
- PCOS and insulin resistance have a strong clinical association.
- PCOS and hyperinsulinemia are a common metabolic association.
How Is PCOS Connected to Infertility?
PCOS is particularly important in reproductive health because disrupted or absent ovulation can make conception more difficult.
| Fertility Indicator | PCOS Relationship |
| PCOS and anovulation | Major association |
| PCOS as a cause of anovulation | Most common cause globally |
| PCOS and infertility | Leading association |
| Irregular ovulation | Common feature |
| Absent ovulation | Common in affected patients |
| Ovulation induction | Major treatment pathway |
Source: WHO and international evidence-based PCOS guideline.
PCOS is the leading cause of anovulatory infertility, thus accounting for roughly 80% to 95% of cases where women fail to release an egg because of ovulatory dysfunction. It is the single most common cause of anovulation, which is the lack of ovulation, and anovulatory infertility in women worldwide. Irregular ovulation, also known as oligovulation, is a common feature of hormonal imbalances that cause unpredictable or infrequent release of eggs from the ovaries.
Absent ovulation, also called anovulation, occurs when the ovaries fail to release an egg during a menstrual cycle. This condition is often associated with subfertility and irregular menstrual bleeding. Ovulation induction is a medical treatment that utilizes hormonal medications to stimulate the ovaries and trigger the release of mature eggs.
What Are the Main Metabolic Conditions Associated With PCOS?
PCOS extends beyond reproductive symptoms and is associated with several metabolic and cardiovascular risk factors.
| Associated Condition / Risk | Relationship With PCOS |
| Insulin resistance | Strong association |
| Hyperinsulinemia | Strong association |
| Type 2 diabetes | Increased risk |
| Obesity | Increased prevalence/association |
| Dyslipidemia | Increased risk |
| Hypertension | Increased risk |
| Cardiometabolic disease | Increased risk |
| Cardiovascular risk factors | Increased risk |
Source: CDC, international PCOS guideline, and peer-reviewed evidence.
Insulin resistance and hyperinsulinemia are strongly associated because they form a compensatory as well as cyclical loop where one directly triggers the other. Research also states that women with elevated body mass index (BMI) have a substantially higher risk of developing PCOS, with high-BMI individuals facing up to a threefold to fivefold greater risk of manifestation compared to non-obese individuals.
Dyslipidemia, type 2 diabetes, and hypertension are closely linked because they share common underlying causes such as insulin resistance, chronic inflammation, and blood vessel damage. High blood sugar and abnormal fats injure the inner lining of arteries. This damage stiffens blood vessels and thus raises blood pressure. Together, they dramatically increase the chance of heart attacks, strokes, and even blood flow problems because they accelerate arterial damage and force the heart to work harder.
Which Hormonal and Physical Symptoms Are Associated With PCOS?
Androgen excess can produce several of the visible symptoms commonly associated with PCOS.
| Symptom/Hormonal Feature | PCOS Association |
| Elevated androgen activity | Core diagnostic feature |
| Excess facial hair | Common |
| Excess body hair | Common |
| Acne | Common |
| Oily skin | Common |
| Scalp hair thinning | Common |
| Male-pattern hair loss | Possible |
| Irregular ovulation | Common |
| Irregular menstrual cycles | Common |
| Infertility | Associated consequence |
Source: FDA and WHO.
Hormonal/physical symptoms of PCOS include elevated androgen activity, which is a core diagnostic feature. Excess facial hair, body hair, acne, oily skin, scalp hair thinning, irregular ovulation, and irregular menstrual cycles are commonly seen, along with male-pattern hair loss with possible infertility-associated consequences. In PCOS, high levels of male hormones disrupt hair growth cycles to cause scalp hair loss as well as prevent regular egg release, which leads to infertility. Extra androgens turn into a stronger hormone known as DHT, and high androgens stop the ovaries from maturing and then releasing eggs each month.
What PCOS Symptoms Can Appear on the Skin?
Dermatological manifestations can sometimes be among the first visible signs that lead someone to seek medical evaluation.
| Skin/Hair Manifestation | PCOS Association |
| Acne | Common |
| Oily skin | Common |
| Facial hair growth | Common |
| Body hair growth | Common |
| Scalp hair thinning | Common |
| Male-pattern baldness | Possible |
| Darkened skin around neck | Associated |
| Darkened skin in groin | Associated |
| Darkened skin beneath breasts | Associated |
| Skin tags | Associated |
Source: FDA. Acne, oily skin, facial hair growth, body hair growth, and scalp hair thinning are common. Male-pattern baldness is possible. Darkened skin around the neck, darkened skin in the groin, darkened skin beneath the breasts, and skin tags are associated. PCOS symptoms appear on the skin as the condition causes high levels of male hormones (androgens) and insulin resistance, which directly change how skin and hair cells grow. Further, insulin resistance means the body makes extra insulin, and high insulin levels signal skin cells to multiply fast, thus creating thick, dark, and velvety patches in body folds such as the neck and armpits.
At What Age Can PCOS Occur?
PCOS can become clinically apparent during adolescence and continue throughout reproductive life, although diagnosis in adolescents requires careful assessment.
| Age / Life Stage | PCOS Relevance |
| Childhood | PCOS is generally not diagnosed solely on adult criteria |
| Adolescence | Symptoms can emerge |
| As young as 11 years | PCOS can occur |
| Reproductive age | Main affected population |
| Young adulthood | Common period for diagnosis |
| Later reproductive years | Symptoms and metabolic risks may persist |
Source: CDC/NHANES and international PCOS guidelines.
Age matters in PCOS because the condition changes, and even its main health risks shift as a person moves through different life stages. In childhood, PCOS is generally not diagnosed solely on adult criteria; in adolescence, the symptoms can emerge but are not visible. As young as 11 years old, PCOS can occur. Reproductive age is the primarily affected population; young adulthood is the common period for diagnosis. In later reproductive years, symptoms and metabolic risks may persist.
What Are the Main PCOS Diagnosis Criteria?
PCOS diagnosis is not based on a single symptom. International guidelines use a combination of reproductive, hormonal, and ovarian characteristics.
| Diagnostic Feature | Role |
| Hyperandrogenism | Major diagnostic feature |
| Clinical hyperandrogenism | Major diagnostic feature |
| Biochemical hyperandrogenism | Major diagnostic feature |
| Ovulatory dysfunction | Major diagnostic feature |
| Irregular menstrual cycles | Important indicator |
| Polycystic ovarian morphology | Diagnostic component in appropriate patients |
| Other causes excluded | Required for appropriate diagnosis |
Source: 2023 International Evidence-Based Guideline.
Accurate PCOS diagnosis criteria are significant because they ensure timely medical intervention for a complex, multi-system condition that later impacts reproductive, metabolic, and psychological health. Because symptoms such as acne, weight fluctuations, and even irregular cycles usually mimic normal puberty or stress, structured definitions prevent years of diagnostic delay. Hyperandrogenism, clinical hyperandrogenism, biochemical hyperandrogenism, and ovulatory dysfunction are major diagnostic features. Irregular menstrual cycles are an important indicator. Polycystic ovarian morphology is a diagnostic component in appropriate patients, and exclusion of other causes is required for an appropriate diagnosis.
What Are the Major PCOS Healthcare Management Areas?
This table is useful if you want to connect the article with healthcare companies, pharmaceutical companies, diagnostics, and fertility services.
| Management Area | Primary Objective |
| Lifestyle management | Weight and metabolic health |
| Menstrual-cycle management | Cycle regulation |
| Hormonal therapy | Manage androgen-related/r.eproductive symptoms |
| Metabolic management | Address insulin resistance and metabolic risk. |
| Acne treatment | Manage dermatological symptoms |
| Hirsutism treatment | Reduce unwanted hair growth. |
| Ovulation induction | Support conception |
| Fertility treatment | Address infertility |
| Glucose monitoring | Identify metabolic abnormalities |
| Psychological support | Address mental-health and quality-of-life concerns. |
The international guideline identifies lifestyle management as a core component of PCOS care and recommends individualized management according to symptoms, reproductive goals, and metabolic risk.
Major PCOS healthcare management areas focus on lifestyle modification, hormonal balance, fertility support, metabolic health, and psychological care. For instance, Lifestyle and Weight Management with healthy nutrition and regular physical activity like walking or yoga enhance insulin sensitivity. Modest weight loss aids in restoring ovulation and regular menstrual cycles. Fertility and Pregnancy Support: Ovulation induction treatments such as letrozole or clomiphene aid with conception. Advanced fertility options such as in vitro fertilization (IVF) are available if first-line treatments fail.
What are the Future Trends of PCOS?
The future of PCOS focuses on reducing the burden of PCOS among vulnerable populations and increasing awareness through several measures. Emerging economies are experiencing improved healthcare resources, leading to higher diagnosis rates, driven by large populations, rapid economic transition, and nutritional transition. In addition, developed nations benefit from increased awareness and the easy availability of diagnostic technologies.
Ongoing research aims to develop a clear understanding of the pathophysiology of PCOS and generate novel drugs through advanced computational approaches. Numerous research organizations provide funding to support research activities. Regulatory authorities aim to improve coverage and treatment access for non-reproductive manifestations. Thus, PCOS is shifting from a narrow focus on reproduction toward a lifelong metabolic and endocrine framework.
About the Authors
Aditi Shivarkar
Aditi, Vice President at Precedence Research, brings over 15 years of expertise at the intersection of technology, innovation, and strategic market intelligence. A visionary leader, she excels in transforming complex data into actionable insights that empower businesses to thrive in dynamic markets. Her leadership combines analytical precision with forward-thinking strategy, driving measurable growth, competitive advantage, and lasting impact across industries.
Aman Singh
Aman Singh with over 13 years of progressive expertise at the intersection of technology, innovation, and strategic market intelligence, Aman Singh stands as a leading authority in global research and consulting. Renowned for his ability to decode complex technological transformations, he provides forward-looking insights that drive strategic decision-making. At Precedence Research, Aman leads a global team of analysts, fostering a culture of research excellence, analytical precision, and visionary thinking.
Piyush Pawar
Piyush Pawar brings over a decade of experience as Senior Manager, Sales & Business Growth, acting as the essential liaison between clients and our research authors. He translates sophisticated insights into practical strategies, ensuring client objectives are met with precision. Piyush’s expertise in market dynamics, relationship management, and strategic execution enables organizations to leverage intelligence effectively, achieving operational excellence, innovation, and sustained growth.
Request Consultation